Pulse oximetry screening for congenital heart disease. Does it work? Is it worth it?

Slides:



Advertisements
Similar presentations
March 5, 2007Manitoba NRP Advisory Group Use of Oxygen during Resuscitation of Neonates John Baier.
Advertisements

Quad Network Study Day Anju Singh, SV Rasiah, Andy Ewer 29/11/2012.
Acyanotic Heart Disease PRECIOUS PEDERSEN INTRODUCTION Left to right shunting lesions, increased pulmonary blood flow The blood is shunted through.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Potential Impact of CCHD Screening Peterson C, Ailes E, Riehle-Colarusso T, et al.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Congenital Heart Disease in Neonates EGM Hoosen Paediatric Cardiology Inkosi Albert Luthuli Central Hospital.
Invasive test results CHD Astraia-search CHD Q-diagnoses CHD* * CHD=structural congenital heart disease ** Right aortic arch, persistent arterial duct.
Is it True? Evaluating Research about Diagnostic Tests
Pulse Oximetry Screening in the Asymptomatic Newborn: Science, Politics and Media Ashish B. Shah MD, MBA Arizona Pediatric Cardiology Consultants Lancaster.
An Introduction to Advocacy Issues. Agenda The Nuts and Bolts of Screening, Dr. Paul Matherne Overview of Benefits and Potential Obstacles, Dr. John Hokansen.
Newborn Screening for Critical Congenital Heart Disease
Screening for Critical Congenital Heart Disease using Pulse Oximetry Legislative Advocacy Anoop Rao PGY2, Pediatrics Image
Early management of congenital heart diseases Jameel A. AL-Ata Consultant & assistant professor of pediatrics & pediatric cardiology.
HOW TO DEAL WITH A NEWBORN BABY WITH CONGENITAL HEART DISEASE ?
Critical Congenital Heart Disease Screening Saving Lives One Infant at a Time Christina Rust, MSN, RN.
Newborn Screening for Critical Congenital Heart Defects by Pulse Oximetry Fall CME Course 2012 Robert Jansen, MD St. Vincent Women’s Hospital.
Screening PHIL THIRKELL. What is screening?  A process of identifying apparently healthy people who may be at risk of a disease or condition  Identify.
Information Mastery: A Practical Approach to Evidence-Based Care Course Directors: Allen Shaughnessy, PharmD, MMedEd David Slawson, MD Tufts Health Care.
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
First Trimester Screening
2014 Summit Co-Convener:Founder: Patient Safety Science & Technology Summit 2014.
Max Brinsmead MB BS PhD May  In the UK this has increased over time  Deaths in 1982 – per million births  in 2003 – per million.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
Fetal Checkup-for whom? : Review on the problems of Prenatal Diagnosis Checkup in Korea Park So Young Catholic University of KOREA
Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.
SOCIAL OBSTETRICS Defined as the study of the interplay of social and environmental factors and human reproduction going back to preconceptional.
Congenital Heart Disease in Children Dr. Sara Mitchell January
CYANOTIC CONGENITAL HEART DISEASE
Child Health Eight week check Elaine Burfitt July 2010.
Screening Puja Myles
© The Children's Mercy Hospital, /14 Critical Congenital Heart Disease (CCHD) Meagan Dorton, MSN, MBA, RN-CPN Pulse Oximetry Screening for Detecting.
Preterm Labor & Preterm Birth Family Medicine Specialist CME Vientiane, Lao PDR December 10 – 12, 2008.
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
“I’ve heard a murmur…” Now what? A presentation by the founders of CHD Warriors.
The contribution of pulse oximetry to the early detection of congenital heart disease in newborns Romaine Arlettaz, Andrea Seraina Bauschatz, Marion Mönkhoff,
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
C ASE REPORT FOR V. GRADE STUDENTS Cardiology Dr. Kemény Viktória.
CONGENITAL HEART DISEASES
Dr David Roden Neonatologist Staffordshire, Shropshire and Black Country Newborn Network.
ANTENATAL CARE OF DIABETES IN PREGNANCY: AUDIT Rachael Read ST2 O&G Supervisor: Mr E Njiforfut Consultant.
Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.
Keith Reed - Tamba. About The Report Completed - Between August 2013 and February 2014 Responses – 3,728 responses from 6 countries Questions – Birth.
Why? 1 in 100 newborns have congenital heart defects 25% of all CHD are critical (CCHD) requiring intervention in the.
Congenital Heart Disease in South Texas Nadine Aldahhan, D.O.; Cherie Johnson, M.D., FACOG, MMM; Priscilla Gutierrez, RDMS, RDCS, RVT Christus Spohn Family.
Congenital Heart Disease
Telephonic survey of the use of pulse oximetry as part of routine baby checks S Goyal, S Sen.
MANDATE Maternal and Neonatal Directed Assessment of Technology GBCHealth November 29, 2011.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Recognition of Congenital Heart Disease Prenatal and newborn M. Beth Goens, MD Pediatric Cardiology University of New Mexico.
Automated Echo | Rapid Heart Imaging
Sudden Unexpected Postnatal Collapse
Essential Paediatric Cardiology for Primary Care
Screening for Critical Congenital Heart Defects with pulse oximetry:
The cardiovascular system
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck for medical institution internal education or training.
Obstetric and paediatric HIV surveillance data from the UK and Ireland
Maternal health and the health of Australian Babies
ECHO SCREENING CLINICAL SESSION
Multidisciplinary counselling reduces rate of abortion and improves clinical outcomes of prenatally diagnosed congenital heart disease patients.
Obstetric and paediatric HIV surveillance data from the UK and Ireland
Etiology of Acute Kidney Injury in Neonates
Obstetric and paediatric HIV surveillance data from the UK and Ireland
Local Tobacco Control Profiles The webinar will start at 1pm
CYANOTIC CONGENITAL HEART DISEASE
Network audit and quality improvement
Your unborn baby has been diagnosed with a heart problem
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Obstetric / Specialist / Mother & Baby Care
Fetal cardiology service evaluation Antenatal diagnosis rate 2017
Presentation transcript:

Pulse oximetry screening for congenital heart disease. Does it work? Is it worth it?

Congenital Heart Disease Most common group of congenital anomalies About 1 in every 100 babies – Depends on definition – If you include all ASD, VSD found on screening ultrasounds, 1% At least 8 per thousand have anomly with clinical impact

Congenital Heart Disease Sometimes not detected before discharge home Infants with CHD who present after a serious deterioration have higher mortality and higher morbidity Often, patients who had duct dependent lesions, who present when the duct closes

Congenital Heart Disease Can we detect CHD before that happens Antenatal screening Postnatal screening

The target diagnosis Critical congenital heart disease (CCHD) CHD which is duct dependant and may cause sudden severe illness after PDA closure, and CHD which requires surgery in the 1 st 28 days of life Includes most cyanotic CHD, and left heart obstructive lesions

How many CCHD are missed? Most pregnant women have a morphology scan around 20 weeks gestation All babies born in hospital have a physical exam before hospital discharge Nevertheless at least 20% of babies with CCHD are discharged without a diagnosis (data from UK)

CCHD in Canada Are we missing CCHD in Canada? No recent data CCHD about 1 per 1000 births If we are better than any other jurisdiction, then about 10% not diagnosed before discharge 1 baby in every 10,000 discharged from hospital with CCHD without diagnosis

Does Oximetry Screening work? Several very large studies de Wahl-Granelli – Only 2 antenatal diagnoses, 40,000 babies Ewer – 23 antenatal diagnoses, 20,000 babies

Is there a lot of extra work for the cardiologists? False positive rate between 0.1% and 1% Much lower if tested after 24 hours False positive of physical examination 2%

False positives Many ‘false positives’ actually have diseases that need therapy, or follow up Respiratory disease with desaturation CHD which is not ‘critical` Pulmonary hypertension

Do false positives worry parents? UK study of babies 119 false positives Asked the mothers No increase in anxiety

Sensitivity is around 75% Sensitivity of physical exam alone 66% Combined sensitivity of oximetry with physical exam 83%

False negatives 17% of infants with CCHD which was not diagnosed antenatally will still be discharged without diagnosis Mostly Coarctations, IAA occasionally others (TGA…) Must be sure that parents know (just as with other screens) that a negative screen is not 100%, and babies still need normal health care

Is it worth it? Neonatal Screening costs How to calculate the benefit CCHD screening by pulse oximetry in a society which has widespread morphology ultrasounds About 25000$ per extra case of CCHD detected A bit more expensive than hearing screening Much cheaper than MassSpec CCHD is treatable!

Evidence based recommendations Screen before discharge After 24 hours is preferable (same recommendations as hearing screen) Motion resistant pulse oximeter Foot saturation <95% +|- right hand to foot difference >3% – Either simultaneous or do foot first, then right hand if foot is 95% or 96% Immediate physical exam, if completely normal repeat oximetry If repeat abnormal, or physical exam abnormal, echocardiography, the same day.

neonatalresearch.org